ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

In Brief: O’Brien Will Leave USC To Become Medical School Dean At Creighton; DRCCA Adds New Staff Members

May 14, 1982

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

FDA developing guidelines for oncology endpoints.

May 7, 2004

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010